TY - STD TI - Guideline IH. Integrated addendum to ICH E6 (R1): guideline for good clinical practice E6 (R2). Current Step. 2015;2:1–60. ID - ref1 ER - TY - BOOK PY - 2014 DA - 2014// TI - Contemporary issues for protecting patients in cancer research: workshop summary PB - The National Academies Press CY - Washington, DC ID - ref2 ER - TY - JOUR AU - Speers, M. A. PY - 2005 DA - 2005// TI - Making human research safe: why we cannot afford to fail JO - Sci Eng Ethics VL - 11 UR - https://doi.org/10.1007/s11948-005-0055-7 DO - 10.1007/s11948-005-0055-7 ID - Speers2005 ER - TY - JOUR AU - Lisook, A. B. PY - 1990 DA - 1990// TI - FDA audits of clinical studies: policy and procedure JO - J Clin Pharmacol VL - 30 UR - https://doi.org/10.1002/j.1552-4604.1990.tb03597.x DO - 10.1002/j.1552-4604.1990.tb03597.x ID - Lisook1990 ER - TY - BOOK AU - Fleiss, J. L. PY - 1981 DA - 1981// TI - Statistical methods for rates and proportions PB - Wiley CY - New York ID - Fleiss1981 ER - TY - JOUR AU - Park, S. AU - Noh, Y. H. AU - Rha, S. Y. AU - Kim, W. H. AU - Cheon, J. H. PY - 2015 DA - 2015// TI - Institutional board review for clinical investigations on inflammatory bowel diseases: a single-center study JO - Intest res VL - 13 UR - https://doi.org/10.5217/ir.2015.13.3.274 DO - 10.5217/ir.2015.13.3.274 ID - Park2015 ER - TY - JOUR AU - Glickman, S. W. AU - McHutchison, J. G. AU - Peterson, E. D. AU - Cairns, C. B. AU - Harrington, R. A. AU - Califf, R. M. PY - 2009 DA - 2009// TI - Ethical and scientific implications of the globalization of clinical research JO - NEJM VL - 360 UR - https://doi.org/10.1056/NEJMsb0803929 DO - 10.1056/NEJMsb0803929 ID - Glickman2009 ER - TY - JOUR AU - Bhatt, A. PY - 2011 DA - 2011// TI - Quality of clinical trials: a moving target JO - Perspect Clin Res VL - 2 UR - https://doi.org/10.4103/2229-3485.86880 DO - 10.4103/2229-3485.86880 ID - Bhatt2011 ER - TY - JOUR AU - Hattemer-Apostel, R. PY - 2000 DA - 2000// TI - GCP auditors: hard to find—hard to develop—hard to keep: I. criteria and methods for candidate selection JO - Qual Assur J VL - 4 UR - https://doi.org/3.0.CO;2-I DO - 3.0.CO;2-I ID - Hattemer-Apostel2000 ER - TY - JOUR AU - Califf, R. M. AU - Karnash, S. L. AU - Woodlief, L. H. PY - 1997 DA - 1997// TI - Developing systems for cost-effective auditing of clinical trials JO - Control Clin Trials VL - 18 UR - https://doi.org/10.1016/S0197-2456(96)00237-1 DO - 10.1016/S0197-2456(96)00237-1 ID - Califf1997 ER - TY - JOUR AU - Brosteanu, O. AU - Houben, P. AU - Ihrig, K. AU - Ohmann, C. AU - Paulus, U. AU - Pfistner, B. PY - 2009 DA - 2009// TI - Risk analysis and risk adapted on-site monitoring in noncommercial clinical trials JO - Clin Trials VL - 6 UR - https://doi.org/10.1177/1740774509347398 DO - 10.1177/1740774509347398 ID - Brosteanu2009 ER - TY - BOOK PY - 2013 DA - 2013// TI - Guidance for industry: oversight of clinical investigations—a risk-based approach to monitoring PB - FDA CY - Silver Spring ID - ref12 ER - TY - JOUR AU - Morgan-Linnell, S. K. AU - Stewart, D. J. AU - Kurzrock, R. PY - 2014 DA - 2014// TI - U.S. Food and Drug Administration inspections of clinical investigators: overview of results from 1977 to 2009 JO - Clin Cancer R VL - 20 UR - https://doi.org/10.1158/1078-0432.CCR-13-3206 DO - 10.1158/1078-0432.CCR-13-3206 ID - Morgan-Linnell2014 ER - TY - JOUR AU - Baigent, C. AU - Harrell, F. E. AU - Buyse, M. AU - Emberson, J. R. AU - Altman, D. G. PY - 2008 DA - 2008// TI - Ensuring trial validity by data quality assurance and diversification of monitoring methods JO - Clin Trials. VL - 5 UR - https://doi.org/10.1177/1740774507087554 DO - 10.1177/1740774507087554 ID - Baigent2008 ER -